NEK2 and central nervous system cancer: To verify if NEK2 is involved in the malignant progression of glioma, several public datasets were used to examine the mRNA expression level of NEK2 within different grades of glioma, including TCGA, GRAVENDEEL, REMBRANDT and GILL datasets.